The Use of Peripheral Extracellular Vesicles for Identification of Molecular Biomarkers in a Solid Tumor Mouse Model

  • Noemí García-Romero
  • Gorjana Rackov
  • Cristobal Belda-Iniesta
  • Ángel Ayuso-SacidoEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1660)


Extracellular vesicles (EVs) have been increasingly recognized as a potential source of disease biomarkers, since they contain a multitude of biologically active protein, DNA and RNA species, and they can be retrieved from circulating blood of patients. Here, we describe a protocol for DNA extraction from exosomes, shedding microvesicles and apoptotic bodies isolated from peripheral blood in a mouse xenograft model of solid tumor. In this model, human DNA isolated from tumor-derived EVs can be readily distinguished from the one of the hosts, which is of particular interest for studies aimed at molecular characterization of tumor biomarkers.

Key words

Extracellular vesicles Glioblastoma Xenograft Biomarkers Peripheral blood 



This work was supported in part by grants from Health Research Fund (Fondo de Investigaciones Sanitarias, FIS), Carlos III Health Institute (PI10/01069, CP11/00147, and PI14/00077), Plan Estatal I + D + I 2013–2016, and Ministerio de Economía y Competitividad (RTC-2015-3846-1) (A.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Noemí García-Romero and Gorjana Rackov contributed equally to this work.


  1. 1.
    Harding C, Heuser J, Stahl P (1983) Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97:329–339CrossRefPubMedGoogle Scholar
  2. 2.
    Pan BT, Teng K, Wu C et al (1985) Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 101:942–948CrossRefPubMedGoogle Scholar
  3. 3.
    Al-Nedawi K, Meehan B, Rak J (2009) Microvesicles: messengers and mediators of tumor progression. Cell Cycle 8:2014–2018CrossRefPubMedGoogle Scholar
  4. 4.
    Chaput N, Théry C (2011) Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 33(5):419–440CrossRefPubMedGoogle Scholar
  5. 5.
    Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Borges FT, LA R, Schor N (2013) Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res 46:824–830CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Momen-Heravi F, Balaj L, Alian S et al (2013) Current methods for the isolation of extracellular vesicles. Biol Chem 394:1253–1262CrossRefPubMedGoogle Scholar
  8. 8.
    Doeing DC, Borowicz JL, Crockett ET (2003) Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin Pathol 3:3CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Witwer KW, Buzás EI, Bemis LT et al (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2:1–25CrossRefGoogle Scholar
  10. 10.
    James GN, Thoi LL, McManus LM, Reimann TA (1982) Isolation of human platelet membrane microparticles from plasma and serum. Blood 60:834–841Google Scholar
  11. 11.
    Jayachandran M, Miller VM, Heit JA, Owen WG (2012) Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods 375:207–214Google Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Noemí García-Romero
    • 1
    • 2
  • Gorjana Rackov
    • 1
    • 2
  • Cristobal Belda-Iniesta
    • 2
  • Ángel Ayuso-Sacido
    • 1
    • 2
    • 3
    Email author
  1. 1.Instituto Madrileño de Estudios AvanzadosIMDEA NanocienciaMadridSpain
  2. 2.Fundación de Investigación HM HospitalesHospital de Madrid GroupMadridSpain
  3. 3.Instituto de Medicina Molecular Aplicada (IMMA), School of MedicineSan Pablo-CEU UniversityMadridSpain

Personalised recommendations